Jun-ying Li

TRIM34 modulates influenza virus-activated programmed cell death by targeting Z-DNA-binding protein 1 for K63-linked polyubiquitination

Li Wang, Jie Liu, Xiaoyan Wang, 2022, The Journal of biological chemistry.

COVID-19 in patients with multiple myeloma: a cross-sectional survey from the most severely affected region in China

Yadan Wang, Chun Zhang, Hongxiang Wang, 2020, Leukemia & lymphoma.

Clinical characteristics and risk factors for symptomatic venous thromboembolism in hospitalized COVID‐19 patients: A multicenter retrospective study

G. Lip, P. Peng, N. Xiong, 2021, Journal of Thrombosis and Haemostasis.

Idarubicin-Intensified Hematopoietic Cell Transplantation Improves Relapse and Survival of High-Risk Acute Leukemia Patients with Minimal Residual Disease.

Huafang Wang, W. Shi, Jun Fang, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Nanopore-targeted sequencing for simultaneous diagnosis of suspected sepsis and early targeted therapy

Yu Hu, L. Xia, Gaigai Shen, 2021, Annals of translational medicine.

siRNA-mediated inhibition of endogenous brain‑derived neurotrophic factor gene modulates the biological behavior of HeLa cells.

Jing Huang, Lei Chen, Chunyan Sun, 2017, Oncology reports.

Hematological Questions in Personalized Management of COVID-19 Vaccination

Yu Hu, Ting-Huan Wu, Liang V. Tang, 2023, Journal of personalized medicine.

MicroRNA‐324‐5p regulates stemness, pathogenesis and sensitivity to bortezomib in multiple myeloma cells by targeting hedgehog signaling

L. Tang, Lei Chen, Yu Hu, 2018, International journal of cancer.

Efficacy and safety of bortezomib maintenance in patients with newly diagnosed multiple myeloma: a meta-analysis

Lei Chen, Chunyan Sun, Yu Hu, 2017, Bioscience reports.

Safety and efficacy of convalescent plasma therapy in severely and critically ill patients with COVID-19: a systematic review with meta-analysis

Lu Wenjing, Liang V. Tang, Jun-ying Li, 2020, Aging.

Preliminary Results from the Launch Study-a Multicenter, Open-Label Study of Selinexor, Dexamethasone and Chemotherapy Drugs in Relapsed/ Refractory Multiple Myeloma

Chun Zhang, Chunyan Sun, Jun-ying Li, 2022, Blood.

The predictive value of MiR-221 in cancer chemoresistance: a systematic review and meta-analysis

Yadan Wang, Chunyan Sun, Han Yan, 2023, Expert review of anticancer therapy.